Loading...
CESCA Clinical 2017-07-06T03:50:33+00:00

CESCA Clinical

Using its proprietary AutoXpress® technology platform, Cesca is developing autologous (utilizing the patient’s own cells) stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology and orthopedic markets. The Company is actively seeking co-development partners for these programs.

Building a pipeline around proprietary platform